메뉴 건너뛰기




Volumn 88, Issue 1, 2013, Pages 19-29

Biomolecular markers of cancer-associated thromboembolism

Author keywords

Biomarkers; Cancer associated thromboembolism; Leukocytosis; Risk models; Thrombocytosis; Thromboprophylaxis

Indexed keywords

BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; CYSTEINE PROTEINASE; D DIMER; PADGEM PROTEIN; PLACEBO; PROCOAGULANT; PROTHROMBIN; PROTHROMBIN FRAGMENT 1+2; SEMULOPARIN; THALIDOMIDE; THROMBOPLASTIN; UNCLASSIFIED DRUG;

EID: 84884163684     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2013.02.008     Document Type: Review
Times cited : (31)

References (100)
  • 1
    • 33644597912 scopus 로고    scopus 로고
    • Incidence of venous thromboembolism and its effect on survival among patients with common cancers
    • Chew H.K., Wun T., Harvey D., Zhou H., White R.H. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Archives of Internal Medicine 2006, 166:458-464.
    • (2006) Archives of Internal Medicine , vol.166 , pp. 458-464
    • Chew, H.K.1    Wun, T.2    Harvey, D.3    Zhou, H.4    White, R.H.5
  • 3
    • 34648864383 scopus 로고    scopus 로고
    • Incidence of venous thromboembolism and the impact on survival in breast cancer patients
    • Chew H.K., Wun T., Harvey D.J., Zhou H., White R.H. Incidence of venous thromboembolism and the impact on survival in breast cancer patients. Journal of Clinical Oncology 2007, 25:70-76.
    • (2007) Journal of Clinical Oncology , vol.25 , pp. 70-76
    • Chew, H.K.1    Wun, T.2    Harvey, D.J.3    Zhou, H.4    White, R.H.5
  • 4
    • 33644981137 scopus 로고    scopus 로고
    • Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival
    • Alcalay A., Wun T., Khatri V., et al. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. Journal of Clinical Oncology 2006, 24:1112-1118.
    • (2006) Journal of Clinical Oncology , vol.24 , pp. 1112-1118
    • Alcalay, A.1    Wun, T.2    Khatri, V.3
  • 10
    • 13444256137 scopus 로고    scopus 로고
    • Malignancies, prothrombotic mutations, and the risk of venous thrombosis
    • Blom J.W., Doggen C.J., Osanto S., Rosendaal F.R. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005, 293:715-722.
    • (2005) JAMA , vol.293 , pp. 715-722
    • Blom, J.W.1    Doggen, C.J.2    Osanto, S.3    Rosendaal, F.R.4
  • 11
    • 0037111563 scopus 로고    scopus 로고
    • Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
    • Prandoni P., Lensing A.W., Piccioli A., et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002, 100:3484-3488.
    • (2002) Blood , vol.100 , pp. 3484-3488
    • Prandoni, P.1    Lensing, A.W.2    Piccioli, A.3
  • 12
    • 36049000503 scopus 로고    scopus 로고
    • Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
    • Khorana A.A., Francis C.W., Culakova E., Kuderer N.M., Lyman G.H. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 2007, 110:2339-2346.
    • (2007) Cancer , vol.110 , pp. 2339-2346
    • Khorana, A.A.1    Francis, C.W.2    Culakova, E.3    Kuderer, N.M.4    Lyman, G.H.5
  • 13
    • 29144486069 scopus 로고    scopus 로고
    • Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study
    • Khorana A.A., Francis C.W., Culakova E., Lyman G.H. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer 2005, 104:2822-2829.
    • (2005) Cancer , vol.104 , pp. 2822-2829
    • Khorana, A.A.1    Francis, C.W.2    Culakova, E.3    Lyman, G.H.4
  • 14
    • 78650055834 scopus 로고    scopus 로고
    • Prediction of venous thromboembolism in cancer patients
    • Ay C., Dunkler D., Marosi C., et al. Prediction of venous thromboembolism in cancer patients. Blood 2010, 116:5377-5382.
    • (2010) Blood , vol.116 , pp. 5377-5382
    • Ay, C.1    Dunkler, D.2    Marosi, C.3
  • 15
    • 0942265619 scopus 로고    scopus 로고
    • Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon
    • Otten H.M., Mathijssen J., ten Cate H., et al. Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon. Archives of Internal Medicine 2004, 164:190-194.
    • (2004) Archives of Internal Medicine , vol.164 , pp. 190-194
    • Otten, H.M.1    Mathijssen, J.2    ten Cate, H.3
  • 16
    • 0032935334 scopus 로고    scopus 로고
    • The thrombophilic state induced by therapeutic agents in the cancer patient
    • Lee A.Y., Levine M.N. The thrombophilic state induced by therapeutic agents in the cancer patient. Seminars in Thrombosis and Hemostasis 1999, 25:137-145.
    • (1999) Seminars in Thrombosis and Hemostasis , vol.25 , pp. 137-145
    • Lee, A.Y.1    Levine, M.N.2
  • 17
  • 18
    • 40349103260 scopus 로고    scopus 로고
    • Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
    • Bennett C.L., Silver S.M., Djulbegovic B., et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 2008, 299:914-924.
    • (2008) JAMA , vol.299 , pp. 914-924
    • Bennett, C.L.1    Silver, S.M.2    Djulbegovic, B.3
  • 19
    • 0141452131 scopus 로고    scopus 로고
    • Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin
    • Wun T., Law L., Harvey D., Sieracki B., Scudder S.A., Ryu J.K. Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin. Cancer 2003, 98:1514-1520.
    • (2003) Cancer , vol.98 , pp. 1514-1520
    • Wun, T.1    Law, L.2    Harvey, D.3    Sieracki, B.4    Scudder, S.A.5    Ryu, J.K.6
  • 20
    • 33646905411 scopus 로고    scopus 로고
    • Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients
    • Bohlius J., Wilson J., Seidenfeld J., et al. Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. Journal of the National Cancer Institute 2006, 98:708-714.
    • (2006) Journal of the National Cancer Institute , vol.98 , pp. 708-714
    • Bohlius, J.1    Wilson, J.2    Seidenfeld, J.3
  • 21
    • 34147207484 scopus 로고    scopus 로고
    • Venous thromboembolism and survival in patients with high-grade glioma
    • Simanek R., Vormittag R., Hassler M., et al. Venous thromboembolism and survival in patients with high-grade glioma. Neurooncology 2007, 9:89-95.
    • (2007) Neurooncology , vol.9 , pp. 89-95
    • Simanek, R.1    Vormittag, R.2    Hassler, M.3
  • 23
    • 84884140311 scopus 로고
    • Thrombose und Embolie. Gefässentzündung und septische Infektion [Gesammelte Abhandlungen zur wissenschaftlichen Medicin]. Frankfurt am Main: Von Meidinger & Son; [English translation by Matzdorff AC, Bell WR, in Thrombosis and Emboli. Canton, MA: Science History Publications, 1998; in German]
    • Virchow RLK. Thrombose und Embolie. Gefässentzündung und septische Infektion [Gesammelte Abhandlungen zur wissenschaftlichen Medicin]. Frankfurt am Main: Von Meidinger & Son; 1856, p. 219-732 [English translation by Matzdorff AC, Bell WR, in Thrombosis and Emboli. Canton, MA: Science History Publications, 1998; in German].
    • (1856) , pp. 219-732
    • Virchow, R.L.K.1
  • 24
    • 0019503942 scopus 로고
    • A factor X-activating cysteine protease from malignant tissue
    • Gordon S.G., Cross B.A. A factor X-activating cysteine protease from malignant tissue. Journal of Clinical Investigation 1981, 67:1665-1671.
    • (1981) Journal of Clinical Investigation , vol.67 , pp. 1665-1671
    • Gordon, S.G.1    Cross, B.A.2
  • 26
    • 0036858410 scopus 로고    scopus 로고
    • The hypercoagulable state of malignancy: pathogenesis and current debate
    • Caine G.J., Stonelake P.S., Lip G.Y., Kehoe S.T. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia 2002, 4:465-473.
    • (2002) Neoplasia , vol.4 , pp. 465-473
    • Caine, G.J.1    Stonelake, P.S.2    Lip, G.Y.3    Kehoe, S.T.4
  • 27
    • 0037362704 scopus 로고    scopus 로고
    • Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets
    • Muller I., Klocke A., Alex M., et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB Journal 2003, 17:476-478.
    • (2003) FASEB Journal , vol.17 , pp. 476-478
    • Muller, I.1    Klocke, A.2    Alex, M.3
  • 29
    • 60449118289 scopus 로고    scopus 로고
    • Circulating procoagulant microparticles in patients with venous thromboembolism
    • Ay C., Freyssinet J.M., Sailer T., Vormittag R., Pabinger I. Circulating procoagulant microparticles in patients with venous thromboembolism. Thrombosis Research 2009, 123:724-726.
    • (2009) Thrombosis Research , vol.123 , pp. 724-726
    • Ay, C.1    Freyssinet, J.M.2    Sailer, T.3    Vormittag, R.4    Pabinger, I.5
  • 30
    • 43749093560 scopus 로고    scopus 로고
    • Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients
    • Tilley R.E., Holscher T., Belani R., Nieva J., Mackman N. Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. Thrombosis Research 2008, 122:604-609.
    • (2008) Thrombosis Research , vol.122 , pp. 604-609
    • Tilley, R.E.1    Holscher, T.2    Belani, R.3    Nieva, J.4    Mackman, N.5
  • 32
    • 0027162435 scopus 로고
    • C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
    • Cermak J., Key N.S., Bach R.R., Balla J., Jacob H.S., Vercellotti G.M. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993, 82:513-520.
    • (1993) Blood , vol.82 , pp. 513-520
    • Cermak, J.1    Key, N.S.2    Bach, R.R.3    Balla, J.4    Jacob, H.S.5    Vercellotti, G.M.6
  • 33
    • 24344490417 scopus 로고    scopus 로고
    • C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation
    • Cirillo P., Golino P., Calabro P., et al. C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovascular Research 2005, 68:47-55.
    • (2005) Cardiovascular Research , vol.68 , pp. 47-55
    • Cirillo, P.1    Golino, P.2    Calabro, P.3
  • 34
    • 60649120010 scopus 로고    scopus 로고
    • C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo
    • Devaraj S., Dasu M.R., Singh U., Rao L.V., Jialal I. C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo. Atherosclerosis 2009, 203:67-74.
    • (2009) Atherosclerosis , vol.203 , pp. 67-74
    • Devaraj, S.1    Dasu, M.R.2    Singh, U.3    Rao, L.V.4    Jialal, I.5
  • 35
    • 12444303861 scopus 로고    scopus 로고
    • Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin
    • Falati S., Liu Q., Gross P., et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. Journal of Experimental Medicine 2003, 197:1585-1598.
    • (2003) Journal of Experimental Medicine , vol.197 , pp. 1585-1598
    • Falati, S.1    Liu, Q.2    Gross, P.3
  • 36
    • 0034678355 scopus 로고    scopus 로고
    • P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo
    • Frenette P.S., Denis C.V., Weiss L., et al. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. Journal of Experimental Medicine 2000, 191:1413-1422.
    • (2000) Journal of Experimental Medicine , vol.191 , pp. 1413-1422
    • Frenette, P.S.1    Denis, C.V.2    Weiss, L.3
  • 38
    • 78650952222 scopus 로고    scopus 로고
    • Thrombosis risk and survival in cancer patients with elevated C-reactive protein
    • Kanz R., Vukovich T., Vormittag R., et al. Thrombosis risk and survival in cancer patients with elevated C-reactive protein. Journal of Thrombosis and Haemostasis 2011, 9:57-63.
    • (2011) Journal of Thrombosis and Haemostasis , vol.9 , pp. 57-63
    • Kanz, R.1    Vukovich, T.2    Vormittag, R.3
  • 41
    • 0035876016 scopus 로고    scopus 로고
    • Molecular basis for the relationship between thrombosis and cancer
    • Rickles F.R., Falanga A. Molecular basis for the relationship between thrombosis and cancer. Thrombosis Research 2001, 102:V215-V224.
    • (2001) Thrombosis Research , vol.102
    • Rickles, F.R.1    Falanga, A.2
  • 42
    • 67349180253 scopus 로고    scopus 로고
    • Serum C-reactive protein (CRP) levels in cancer patients are linked with tumor burden and are reduced by anti-hypertensive medication
    • Koukourakis M.I., Kambouromiti G., Pitsiava D., Tsousou P., Tsiarkatsi M., Kartalis G. Serum C-reactive protein (CRP) levels in cancer patients are linked with tumor burden and are reduced by anti-hypertensive medication. Inflammation 2009, 32:169-175.
    • (2009) Inflammation , vol.32 , pp. 169-175
    • Koukourakis, M.I.1    Kambouromiti, G.2    Pitsiava, D.3    Tsousou, P.4    Tsiarkatsi, M.5    Kartalis, G.6
  • 43
    • 15344346732 scopus 로고    scopus 로고
    • Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolism
    • Vormittag R., Vukovich T., Schonauer V., et al. Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolism. Thrombosis and Haemostasis 2005, 93:488-493.
    • (2005) Thrombosis and Haemostasis , vol.93 , pp. 488-493
    • Vormittag, R.1    Vukovich, T.2    Schonauer, V.3
  • 44
    • 31544478042 scopus 로고    scopus 로고
    • Risk factors for venous thromboembolic events in cancer patients
    • Kroger K., Weiland D., Ose C., et al. Risk factors for venous thromboembolic events in cancer patients. Annals of Oncology 2006, 17:297-303.
    • (2006) Annals of Oncology , vol.17 , pp. 297-303
    • Kroger, K.1    Weiland, D.2    Ose, C.3
  • 45
    • 70249119693 scopus 로고    scopus 로고
    • D-dimer and prothrombin fragment 1+2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study
    • Ay C., Vormittag R., Dunkler D., et al. D-dimer and prothrombin fragment 1+2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. Journal of Clinical Oncology 2009, 27:4124-4129.
    • (2009) Journal of Clinical Oncology , vol.27 , pp. 4124-4129
    • Ay, C.1    Vormittag, R.2    Dunkler, D.3
  • 46
    • 0036235907 scopus 로고    scopus 로고
    • Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer
    • Kohli M., Fink L.M., Spencer H.J., Zent C.S. Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer. Blood Coagulation and Fibrinolysis 2002, 13:1-5.
    • (2002) Blood Coagulation and Fibrinolysis , vol.13 , pp. 1-5
    • Kohli, M.1    Fink, L.M.2    Spencer, H.J.3    Zent, C.S.4
  • 47
    • 0027276819 scopus 로고
    • Prothrombin fragment F 1+2 plasma concentrations in patients with gynecologic malignancies
    • Hanzal E., Tatra G. Prothrombin fragment F 1+2 plasma concentrations in patients with gynecologic malignancies. Gynecologic Oncology 1993, 49:373-376.
    • (1993) Gynecologic Oncology , vol.49 , pp. 373-376
    • Hanzal, E.1    Tatra, G.2
  • 48
    • 0027400528 scopus 로고
    • Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumour stage and prognosis
    • Seitz R., Rappe N., Kraus M., et al. Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumour stage and prognosis. Blood Coagulation and Fibrinolysis 1993, 4:249-254.
    • (1993) Blood Coagulation and Fibrinolysis , vol.4 , pp. 249-254
    • Seitz, R.1    Rappe, N.2    Kraus, M.3
  • 49
    • 77956907268 scopus 로고    scopus 로고
    • Elevated D-dimers are also a marker of underlying malignancy and increased mortality in the absence of venous thromboembolism
    • Knowlson L., Bacchu S., Paneesha S., McManus A., Randall K., Rose P. Elevated D-dimers are also a marker of underlying malignancy and increased mortality in the absence of venous thromboembolism. Journal of Clinical Pathology 2010, 63:818-822.
    • (2010) Journal of Clinical Pathology , vol.63 , pp. 818-822
    • Knowlson, L.1    Bacchu, S.2    Paneesha, S.3    McManus, A.4    Randall, K.5    Rose, P.6
  • 50
    • 45749130204 scopus 로고    scopus 로고
    • Elevated levels of prothrombin fragment 1+2 indicate high risk of thrombosis
    • Ota S., Wada H., Abe Y., et al. Elevated levels of prothrombin fragment 1+2 indicate high risk of thrombosis. Clinical and Applied Thrombosis and Hemostasis 2008, 14:279-285.
    • (2008) Clinical and Applied Thrombosis and Hemostasis , vol.14 , pp. 279-285
    • Ota, S.1    Wada, H.2    Abe, Y.3
  • 51
    • 0030982676 scopus 로고    scopus 로고
    • Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolism
    • Kyrle P.A., Eichinger S., Pabinger I., et al. Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolism. Thrombosis and Haemostasis 1997, 77:829-833.
    • (1997) Thrombosis and Haemostasis , vol.77 , pp. 829-833
    • Kyrle, P.A.1    Eichinger, S.2    Pabinger, I.3
  • 52
    • 2342439962 scopus 로고    scopus 로고
    • Clotting activation after oral anticoagulant therapy discontinuation: a risk factor for recurrent venous thromboembolism
    • Poli D., Antonucci E., Cecchi E., et al. Clotting activation after oral anticoagulant therapy discontinuation: a risk factor for recurrent venous thromboembolism. Blood Coagulation and Fibrinolysis 2004, 15:221-225.
    • (2004) Blood Coagulation and Fibrinolysis , vol.15 , pp. 221-225
    • Poli, D.1    Antonucci, E.2    Cecchi, E.3
  • 53
    • 79957517025 scopus 로고    scopus 로고
    • Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study
    • Ay C., Dunkler D., Simanek R., et al. Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study. Journal of Clinical Oncology 2011, 29:2099-2103.
    • (2011) Journal of Clinical Oncology , vol.29 , pp. 2099-2103
    • Ay, C.1    Dunkler, D.2    Simanek, R.3
  • 54
    • 53449093751 scopus 로고    scopus 로고
    • High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
    • Ay C., Simanek R., Vormittag R., et al. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood 2008, 112:2703-2708.
    • (2008) Blood , vol.112 , pp. 2703-2708
    • Ay, C.1    Simanek, R.2    Vormittag, R.3
  • 55
    • 33747508925 scopus 로고    scopus 로고
    • P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis
    • Chen M., Geng J.G. P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Archivum Immunologiae et Therapiae Experimentalis 2006, 54:75-84.
    • (2006) Archivum Immunologiae et Therapiae Experimentalis , vol.54 , pp. 75-84
    • Chen, M.1    Geng, J.G.2
  • 56
    • 3242791115 scopus 로고    scopus 로고
    • P-selectin cell adhesion molecule in inflammation, thrombosis, cancer growth and metastasis
    • Geng J.G., Chen M., Chou K.C. P-selectin cell adhesion molecule in inflammation, thrombosis, cancer growth and metastasis. Current Medicinal Chemistry 2004, 11:2153-2160.
    • (2004) Current Medicinal Chemistry , vol.11 , pp. 2153-2160
    • Geng, J.G.1    Chen, M.2    Chou, K.C.3
  • 58
    • 73849086884 scopus 로고    scopus 로고
    • High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study
    • Vormittag R., Simanek R., Ay C., et al. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study. Arteriosclerosis, Thrombosis, and Vascular Biology 2009, 29:2176-2181.
    • (2009) Arteriosclerosis, Thrombosis, and Vascular Biology , vol.29 , pp. 2176-2181
    • Vormittag, R.1    Simanek, R.2    Ay, C.3
  • 61
    • 0642341991 scopus 로고    scopus 로고
    • Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment
    • Minnema M.C., Fijnheer R., De Groot P.G., Lokhorst H.M. Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment. Journal of Thrombosis and Haemostasis 2003, 1:445-449.
    • (2003) Journal of Thrombosis and Haemostasis , vol.1 , pp. 445-449
    • Minnema, M.C.1    Fijnheer, R.2    De Groot, P.G.3    Lokhorst, H.M.4
  • 62
    • 33846483859 scopus 로고    scopus 로고
    • The effect of venous thromboembolism on survival of cancer patients and its relationship with serum levels of factor VIII and vascular endothelial growth factor: a prospective matched-paired study
    • Dogan M., Demirkazik A., Konuk N., et al. The effect of venous thromboembolism on survival of cancer patients and its relationship with serum levels of factor VIII and vascular endothelial growth factor: a prospective matched-paired study. International Journal of Biological Markers 2006, 21:206-210.
    • (2006) International Journal of Biological Markers , vol.21 , pp. 206-210
    • Dogan, M.1    Demirkazik, A.2    Konuk, N.3
  • 63
    • 77955504709 scopus 로고    scopus 로고
    • Predictive value of tissue factor bearing microparticles in cancer associated thrombosis
    • Zwicker J.I. Predictive value of tissue factor bearing microparticles in cancer associated thrombosis. Thrombosis Research 2010, 125(Suppl. 2):S89-S91.
    • (2010) Thrombosis Research , vol.125 , Issue.SUPPL. 2
    • Zwicker, J.I.1
  • 64
    • 34249806307 scopus 로고    scopus 로고
    • Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer
    • Khorana A.A., Ahrendt S.A., Ryan C.K., et al. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clinical Cancer Research 2007, 13:2870-2875.
    • (2007) Clinical Cancer Research , vol.13 , pp. 2870-2875
    • Khorana, A.A.1    Ahrendt, S.A.2    Ryan, C.K.3
  • 67
    • 33846941576 scopus 로고    scopus 로고
    • Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer
    • Hron G., Kollars M., Weber H., et al. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thrombosis and Haemostasis 2007, 97:119-123.
    • (2007) Thrombosis and Haemostasis , vol.97 , pp. 119-123
    • Hron, G.1    Kollars, M.2    Weber, H.3
  • 68
    • 54149109726 scopus 로고    scopus 로고
    • Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer
    • Khorana A.A., Francis C.W., Menzies K.E., et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. Journal of Thrombosis and Haemostasis 2008, 6:1983-1985.
    • (2008) Journal of Thrombosis and Haemostasis , vol.6 , pp. 1983-1985
    • Khorana, A.A.1    Francis, C.W.2    Menzies, K.E.3
  • 69
    • 77952548349 scopus 로고    scopus 로고
    • Increased microparticle tissue factor activity in cancer patients with Venous thromboembolism
    • Manly D.A., Wang J., Glover S.L., et al. Increased microparticle tissue factor activity in cancer patients with Venous thromboembolism. Thrombosis Research 2010, 125:511-512.
    • (2010) Thrombosis Research , vol.125 , pp. 511-512
    • Manly, D.A.1    Wang, J.2    Glover, S.L.3
  • 70
    • 36048936310 scopus 로고    scopus 로고
    • Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk?
    • White R.H., Chew H., Wun T. Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk?. Thrombosis Research 2007, 120(Suppl. 2):S29-S40.
    • (2007) Thrombosis Research , vol.120 , Issue.SUPPL. 2
    • White, R.H.1    Chew, H.2    Wun, T.3
  • 71
    • 84863475142 scopus 로고    scopus 로고
    • Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients
    • Thaler J., Ay C., Mackman N., et al. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. Journal of Thrombosis and Haemostasis 2012, 10:1363-1370.
    • (2012) Journal of Thrombosis and Haemostasis , vol.10 , pp. 1363-1370
    • Thaler, J.1    Ay, C.2    Mackman, N.3
  • 73
    • 72549102588 scopus 로고    scopus 로고
    • Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy
    • Zwicker J.I., Liebman H.A., Neuberg D., et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clinical Cancer Research 2009, 15:6830-6840.
    • (2009) Clinical Cancer Research , vol.15 , pp. 6830-6840
    • Zwicker, J.I.1    Liebman, H.A.2    Neuberg, D.3
  • 74
    • 79955941687 scopus 로고    scopus 로고
    • Circulating procoagulant microparticles in cancer patients
    • Thaler J., Ay C., Weinstabl H., et al. Circulating procoagulant microparticles in cancer patients. Annals of Hematology 2011, 90:447-453.
    • (2011) Annals of Hematology , vol.90 , pp. 447-453
    • Thaler, J.1    Ay, C.2    Weinstabl, H.3
  • 75
    • 20444433198 scopus 로고    scopus 로고
    • In vitro procoagulant activity induced in endothelial cells by chemotherapy and antiangiogenic drug combinations: modulation by lower-dose chemotherapy
    • Ma L., Francia G., Viloria-Petit A., et al. In vitro procoagulant activity induced in endothelial cells by chemotherapy and antiangiogenic drug combinations: modulation by lower-dose chemotherapy. Cancer Research 2005, 65:5365-5373.
    • (2005) Cancer Research , vol.65 , pp. 5365-5373
    • Ma, L.1    Francia, G.2    Viloria-Petit, A.3
  • 76
    • 63049125016 scopus 로고    scopus 로고
    • Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes
    • Swystun L.L., Shin L.Y., Beaudin S., Liaw P.C. Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes. Journal of Thrombosis and Haemostasis 2009, 7:619-626.
    • (2009) Journal of Thrombosis and Haemostasis , vol.7 , pp. 619-626
    • Swystun, L.L.1    Shin, L.Y.2    Beaudin, S.3    Liaw, P.C.4
  • 77
    • 84866159092 scopus 로고    scopus 로고
    • Clinical significance of circulating microparticles for venous thromboembolism in cancer patients
    • Thaler J., Ay C., Pabinger I. Clinical significance of circulating microparticles for venous thromboembolism in cancer patients. Hamostaseologie 2012, 32:127-131.
    • (2012) Hamostaseologie , vol.32 , pp. 127-131
    • Thaler, J.1    Ay, C.2    Pabinger, I.3
  • 78
    • 13244252408 scopus 로고    scopus 로고
    • Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score
    • Zakai N.A., Wright J., Cushman M. Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score. Journal of Thrombosis and Haemostasis 2004, 2:2156-2161.
    • (2004) Journal of Thrombosis and Haemostasis , vol.2 , pp. 2156-2161
    • Zakai, N.A.1    Wright, J.2    Cushman, M.3
  • 80
    • 0037182012 scopus 로고    scopus 로고
    • Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology
    • Tsai A.W., Cushman M., Rosamond W.D., Heckbert S.R., Polak J.F., Folsom A.R. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Archives of Internal Medicine 2002, 162:1182-1189.
    • (2002) Archives of Internal Medicine , vol.162 , pp. 1182-1189
    • Tsai, A.W.1    Cushman, M.2    Rosamond, W.D.3    Heckbert, S.R.4    Polak, J.F.5    Folsom, A.R.6
  • 81
    • 73049084718 scopus 로고    scopus 로고
    • High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
    • Simanek R., Vormittag R., Ay C., et al. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Journal of Thrombosis and Haemostasis 2010, 8:114-120.
    • (2010) Journal of Thrombosis and Haemostasis , vol.8 , pp. 114-120
    • Simanek, R.1    Vormittag, R.2    Ay, C.3
  • 82
    • 43449115194 scopus 로고    scopus 로고
    • Development and validation of a predictive model for chemotherapy-associated thrombosis
    • Khorana A.A., Kuderer N.M., Culakova E., Lyman G.H., Francis C.W. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008, 111:4902-4907.
    • (2008) Blood , vol.111 , pp. 4902-4907
    • Khorana, A.A.1    Kuderer, N.M.2    Culakova, E.3    Lyman, G.H.4    Francis, C.W.5
  • 84
    • 0035498663 scopus 로고    scopus 로고
    • Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma
    • Kasuga I., Makino S., Kiyokawa H., Katoh H., Ebihara Y., Ohyashiki K. Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer 2001, 92:2399-2405.
    • (2001) Cancer , vol.92 , pp. 2399-2405
    • Kasuga, I.1    Makino, S.2    Kiyokawa, H.3    Katoh, H.4    Ebihara, Y.5    Ohyashiki, K.6
  • 85
    • 24944442592 scopus 로고    scopus 로고
    • Prognostic factors in advanced cancer patients: evidence-based clinical recommendations-a study by the Steering Committee of the European Association for Palliative Care
    • Maltoni M., Caraceni A., Brunelli C., et al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations-a study by the Steering Committee of the European Association for Palliative Care. Journal of Clinical Oncology 2005, 23:6240-6248.
    • (2005) Journal of Clinical Oncology , vol.23 , pp. 6240-6248
    • Maltoni, M.1    Caraceni, A.2    Brunelli, C.3
  • 86
    • 0035184527 scopus 로고    scopus 로고
    • Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance
    • Ruka W., Rutkowski P., Kaminska J., Rysinska A., Steffen J. Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance. Annals of Oncology 2001, 12:1423-1432.
    • (2001) Annals of Oncology , vol.12 , pp. 1423-1432
    • Ruka, W.1    Rutkowski, P.2    Kaminska, J.3    Rysinska, A.4    Steffen, J.5
  • 87
    • 34248218014 scopus 로고    scopus 로고
    • Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial
    • Schmidt H., Suciu S., Punt C.J., et al. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial. Journal of Clinical Oncology 2007, 25:1562-1569.
    • (2007) Journal of Clinical Oncology , vol.25 , pp. 1562-1569
    • Schmidt, H.1    Suciu, S.2    Punt, C.J.3
  • 88
    • 55549112598 scopus 로고    scopus 로고
    • Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry
    • Trujillo-Santos J., Di Micco P., Iannuzzo M., et al. Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry. Thrombosis and Haemostasis 2008, 100:905-911.
    • (2008) Thrombosis and Haemostasis , vol.100 , pp. 905-911
    • Trujillo-Santos, J.1    Di Micco, P.2    Iannuzzo, M.3
  • 89
    • 84862115634 scopus 로고    scopus 로고
    • Risk assessment for cancer-associated thrombosis: what is the best approach?
    • Khorana A.A. Risk assessment for cancer-associated thrombosis: what is the best approach?. Thrombosis Research 2012, 129(Suppl. 1):S10-S15.
    • (2012) Thrombosis Research , vol.129 , Issue.SUPPL. 1
    • Khorana, A.A.1
  • 90
    • 84861732267 scopus 로고    scopus 로고
    • Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the 'SENDO experience'
    • Mandala M., Clerici M., Corradino I., et al. Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the 'SENDO experience'. Annals of Oncology 2012, 23:1416-1421.
    • (2012) Annals of Oncology , vol.23 , pp. 1416-1421
    • Mandala, M.1    Clerici, M.2    Corradino, I.3
  • 91
    • 80052751246 scopus 로고    scopus 로고
    • High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis
    • Moore R.A., Adel N., Riedel E., et al. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis. Journal of Clinical Oncology 2011, 29:3466-3473.
    • (2011) Journal of Clinical Oncology , vol.29 , pp. 3466-3473
    • Moore, R.A.1    Adel, N.2    Riedel, E.3
  • 92
    • 84862227188 scopus 로고    scopus 로고
    • A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score
    • Verso M., Agnelli G., Barni S., Gasparini G., Labianca R. A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score. Internal and Emergency Medicine 2012, 7:291-292.
    • (2012) Internal and Emergency Medicine , vol.7 , pp. 291-292
    • Verso, M.1    Agnelli, G.2    Barni, S.3    Gasparini, G.4    Labianca, R.5
  • 93
    • 84866025241 scopus 로고    scopus 로고
    • Venous thromboembolism (VTE) prevention with semuloparin in cancer patients initiating chemotherapy: benefit-risk assessment by VTE risk in SAVE-ONCO [abstract 206]
    • George D., Agnelli G., Fisher W., et al. Venous thromboembolism (VTE) prevention with semuloparin in cancer patients initiating chemotherapy: benefit-risk assessment by VTE risk in SAVE-ONCO [abstract 206]. Blood 2011, 118.
    • (2011) Blood , vol.118
    • George, D.1    Agnelli, G.2    Fisher, W.3
  • 94
    • 84857129296 scopus 로고    scopus 로고
    • Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer
    • Agnelli G., George D.J., Kakkar A.K., et al. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. New England Journal of Medicine 2012, 366:601-609.
    • (2012) New England Journal of Medicine , vol.366 , pp. 601-609
    • Agnelli, G.1    George, D.J.2    Kakkar, A.K.3
  • 96
    • 70449724622 scopus 로고    scopus 로고
    • Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines
    • Petersen L.J. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines. Cancer Treatment Reviews 2009, 35:754-764.
    • (2009) Cancer Treatment Reviews , vol.35 , pp. 754-764
    • Petersen, L.J.1
  • 97
    • 36849070772 scopus 로고    scopus 로고
    • American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer
    • Lyman G.H., Khorana A.A., Falanga A., et al. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. Journal of Clinical Oncology 2007, 25:5490-5505.
    • (2007) Journal of Clinical Oncology , vol.25 , pp. 5490-5505
    • Lyman, G.H.1    Khorana, A.A.2    Falanga, A.3
  • 98
    • 84856699090 scopus 로고    scopus 로고
    • Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines
    • Guyatt G.H., Akl E.A., Crowther M., Gutterman D.D., Schuunemann H.J. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012, 141:7S-47S.
    • (2012) Chest , vol.141
    • Guyatt, G.H.1    Akl, E.A.2    Crowther, M.3    Gutterman, D.D.4    Schuunemann, H.J.5
  • 99
    • 77955496152 scopus 로고    scopus 로고
    • Prevention and treatment of venous thromboembolism among patients with cancer: the American Society of Clinical Oncology Guidelines
    • Lyman G.H., Kuderer N.M. Prevention and treatment of venous thromboembolism among patients with cancer: the American Society of Clinical Oncology Guidelines. Thrombosis Research 2010, 125(Suppl. 2):S120-S127.
    • (2010) Thrombosis Research , vol.125 , Issue.SUPPL. 2
    • Lyman, G.H.1    Kuderer, N.M.2
  • 100
    • 84857128698 scopus 로고    scopus 로고
    • Routine heparin for patients with cancer? One answer, more questions
    • Akl E.A., Schunemann H.J. Routine heparin for patients with cancer? One answer, more questions. New England Journal of Medicine 2012, 366:661-662.
    • (2012) New England Journal of Medicine , vol.366 , pp. 661-662
    • Akl, E.A.1    Schunemann, H.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.